Adam Inzirillo sold $42k of CBOE
EVP, DATA VANTAGE at Cboe Global Markets, Inc.. 200 shares at an average of $209.67, traded Feb 20, 2025, filed Feb 21, 2025.
Score components
- +15RoleOfficer
- +6Trade size$42k at market
- 0Share of holdings soldSold 9.1% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-005096, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 19, 2025 | MOption exercise Common Stock | +757 | $210.25 | $159k | 1,975 | Feb 21, 2025 |
| Feb 19, 2025 | FTax withholding Common Stock | -385 | $210.25 | $81k | 1,590 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Common Stock | +796 | $210.25 | $167k | 2,386 | Feb 21, 2025 |
| Feb 19, 2025 | FTax withholding Common Stock | -394 | $210.25 | $83k | 1,992 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Common Stock | +41 | $210.25 | $8,620 | 2,033 | Feb 21, 2025 |
| Feb 19, 2025 | FTax withholding Common Stock | -21 | $210.25 | $4,415 | 2,012 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Common Stock | +402 | $210.25 | $85k | 2,414 | Feb 21, 2025 |
| Feb 19, 2025 | FTax withholding Common Stock | -221 | $210.25 | $46k | 2,193 | Feb 21, 2025 |
| Feb 20, 2025 | SOpen-market sale Common Stock | -200 | $209.67 | $42k | 1,993 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Restricted Stock Unitsderivative | -757 | $0.00 | $0 | 0 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Restricted Stock Unitsderivative | -796 | $0.00 | $0 | 796 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Restricted Stock Unitsderivative | -41 | $0.00 | $0 | 42 | Feb 21, 2025 |
| Feb 19, 2025 | MOption exercise Restricted Stock Unitsderivative | -402 | $0.00 | $0 | 804 | Feb 21, 2025 |
| Feb 19, 2025 | AGrant or award Restricted Stock Unitsderivative | +1,190 | $0.00 | $0 | 1,190 | Feb 21, 2025 |
Related signals
Other insiders at Cboe Global Markets, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 48Moderate | Cboe Global Markets, Inc. | Allen Wilkinson SVP, CHIEF ACCOUNTING OFFICER | $73k 248 shares | -38% | |
| 60Notable | Cboe Global Markets, Inc. | Edward J. Fitzpatrick director | $1.1M 3,947 shares | -23% | |
| 52Moderate | Cboe Global Markets, Inc. | Alexander Matturri JR director | $428k 1,500 shares | -24% | |
| 30Weak | Cboe Global Markets, Inc. | Christopher A Isaacson EVP, COO | $1.2M 5,000 shares | -12% | |
| 30Weak | Cboe Global Markets, Inc. | Christopher A Isaacson EVP, COO | $1.1M 5,000 shares | -11% | |
| 37Weak | Cboe Global Markets, Inc. | Catherine R Clay EVP, GLOBAL DERIVATIVES | $815k 3,598 shares | -62% | |
| 39Weak | CBOEsell Cboe Global Markets, Inc. | Jill R Goodman director | $561k 2,684 shares | -19% | |
| 47Moderate | Cboe Global Markets, Inc. | Allen Wilkinson SVP, CHIEF ACCOUNTING OFFICER | $48k 228 shares | -48% | |
| 30Weak | Cboe Global Markets, Inc. | Dave Howson EVP, GLOBAL PRESIDENT | $1.2M 5,659 shares | -41% | |
| 55Moderate | Cboe Global Markets, Inc. | Dave Howson EVP, GLOBAL PRESIDENT | $2.3M 11,036 shares | -58% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.